Misplaced Pages

Demecolcine: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 10:59, 17 February 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Wik← Previous edit Revision as of 11:56, 4 April 2011 edit undoLouisajb (talk | contribs)Extended confirmed users4,402 edits added the data from COLCEMID PAGENext edit →
Line 40: Line 40:
}} }}


'''Demecolcine''' is a drug used in ].It is closely related to the natural ] ] with the replacement of the ] group on the ] moiety with ]. '''Demecolcine''', also known as colcemid, is a drug used in ].It is closely related to the natural ] ] with the replacement of the ] group on the ] moiety with ], but it is less toxic. It ] ] and limits microtubule formation (inactivates ] formation), thus arresting ]s in ] and allowing cell harvest and ] to be performed.


During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.<ref>Brit med J., 1965, 1, 495 – 496</ref> During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.<ref>Brit med J., 1965, 1, 495 – 496</ref>


In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.<ref>Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26</ref> In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.<ref>Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26</ref>

==Mechanism of Action==
Demecolcine is a microtubule-depolymerizing drug like ]. It acts by two distinct mechanisms. At very low concentration it binds to microtubule plus end to suppress microtubule dynamics.<ref>{{cite journal |last1=Jordan |first1=Mary Ann |last2=Wilson |first2=Leslie |title=Microtubules as a target for anticancer drugs |journal=Nature reviews. Cancer |volume=4 |issue=4 |pages=253–65 |year=2004 |pmid=15057285 |doi=10.1038/nrc1317}}</ref> Recent study has found at higher concentration colcemid can promote microtubule detachment from microtubule organizing center. Detached microtubules with unprotected minus end depolymerizes with time. Cytotoxicity of the cells seems to correlate better with ] detachment.<ref name=pmid20696757>{{cite journal |last1=Yang |first1=Hailing |last2=Ganguly |first2=Anutosh |last3=Cabral |first3=Fernando |title=Inhibition of cell migration and cell division correlate with distinct effects of microtubule inhibiting drugs |journal=The Journal of biological chemistry |volume=285 |issue=42 |pages=32242–50 |year=2010 |pmid=20696757 |pmc=2952225 |doi=10.1074/jbc.M110.160820}}</ref> Lower concentration affects microtubule dynamics and cell migration.<ref name=pmid20696757/>


== References == == References ==
Line 54: Line 57:
] ]
] ]
]

]





Revision as of 11:56, 4 April 2011

Pharmaceutical compound
Demecolcine
Clinical data
ATC code
Identifiers
IUPAC name
  • (S)-1,2,3,10-Tetramethoxy-7-methylamino-6,7-dihydro-5H-benzoheptalen-9-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.006.832 Edit this at Wikidata
Chemical and physical data
FormulaC21H25NO5
Molar mass371.43 g/mol g·mol
3D model (JSmol)
SMILES
  • O=C/1C(\OC)=C/C=C2\C(=C\1)(NC)CCc3c2c(OC)c(OC)c(OC)c3
InChI
  • InChI=1S/C21H25NO5/c1-22-15-8-6-12-10-18(25-3)20(26-4)21(27-5)19(12)13-7-9-17(24-2)16(23)11-14(13)15/h7,9-11,15,22H,6,8H2,1-5H3/t15-/m0/s1
  • Key:NNJPGOLRFBJNIW-HNNXBMFYSA-N
  (verify)

Demecolcine, also known as colcemid, is a drug used in chemotherapy.It is closely related to the natural alkaloid colchicine with the replacement of the acetyl group on the amino moiety with methyl, but it is less toxic. It depolymerises microtubules and limits microtubule formation (inactivates spindle fibre formation), thus arresting cells in metaphase and allowing cell harvest and karyotyping to be performed.

During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.

In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.

Mechanism of Action

Demecolcine is a microtubule-depolymerizing drug like vinblastine. It acts by two distinct mechanisms. At very low concentration it binds to microtubule plus end to suppress microtubule dynamics. Recent study has found at higher concentration colcemid can promote microtubule detachment from microtubule organizing center. Detached microtubules with unprotected minus end depolymerizes with time. Cytotoxicity of the cells seems to correlate better with microtubule detachment. Lower concentration affects microtubule dynamics and cell migration.

References

  1. Brit med J., 1965, 1, 495 – 496
  2. Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26
  3. Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature reviews. Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID 15057285.
  4. ^ Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando (2010). "Inhibition of cell migration and cell division correlate with distinct effects of microtubule inhibiting drugs". The Journal of biological chemistry. 285 (42): 32242–50. doi:10.1074/jbc.M110.160820. PMC 2952225. PMID 20696757.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
SPs/MIs
(M phase)
Block microtubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDT
Other
Enzyme inhibitors
Receptor antagonists
Other/ungrouped


Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it.

Categories: